IL-8 in serum and BAL fluid has been shown to be higher in patients with lung cancer than in noncancer controls [35] and the level of IL-8 in BAL fluid can be considered as a prognostic factor for decreased survival [35]. Here, CXCL8 is linked to lung cancer.